A phase 2 with just 10 patients? sounds like there isn't too much to know about it really, plus it's been deprioritised so no point in understanding the difference.
That's a pretty good way to gloss over the liver toxicity's and multiple deaths. But hey as long as we just focus on the positives it's all good.
the poor history is probably the reason why they can't get an ethics approval.
With RC110 now deprioritised , that only gives you one shot at goal. and that can't even get off the ground
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)